Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new medicine that can be prescribed to help treat type 2 diabetes. The SGLT2 inhibitors help to remove excess glucose in the blood through the urine; this allows for the balancing of the glucose and insulin levels in the body. However, there have been cases reported of these SGLT2 inhibitors causing a sickness called diabetic ketoacidosis.
Ketoacidosis is a health complication that occurs when there is excess acid in the body. This happens when your body is not getting enough glucose to use for energy; if the body does not have enough glucose, it creates ketones to compensate. When there are too many ketones in your blood, it becomes acidic. This acidity is poisonous to your body and causes the ketoacidosis. Some of the symptoms of ketoacidosis include high blood sugar, very dry mouth, dry, or flushed skin, constant tiredness, nausea, vomiting, confusion, and difficulty breathing. This is usually related to type 1 diabetes, but it has been shown to occur in type 2 diabetics who have been using SGLT2 inhibitors.
Studies link SGLT2 inhibitors to ketoacidosis
At this point in time, there are investigations being made by the Food and Drug Administration (FDA) to determine the safety of using SGLT2 inhibitors to treat type 2 diabetes. There have been at least twenty reported cases of ketoacidosis in type 2 diabetics who have used one of several SGLT2 inhibitor drugs. Some of these drugs include Xigduo, Invokana, Invokamet, Farxiga, and Glyxambi.
As the SGLT2 inhibitors are being investigated by the FDA, many individuals are coming forward with claims that the drug caused their health problems. These individuals have filed both individual lawsuits and have begun a class action lawsuit that includes all of the SGLT2 inhibitor drugs thought to cause the ketoacidosis.
Lawsuits filed against manufacturers of SGLT2 inhibitors
The lawsuits that have been brought forward regarding the SGLT2 inhibitors are still in the works with no definite outcomes. With the Food and Drug Administration just starting their investigations, it is unsure when the final verdicts will be made public or the outcomes will be made known in relation to the SGLT2 inhibitors.
There is at least one class action suit against the manufacturers of the SGLT2 inhibitors, but this is not the most prevalent form of action. Several lawyers have determined and recommended that it be in the best interest of the individuals suffering from ketoacidosis to file individual suits to make sure that they are getting the compensation that they need to cover their medical costs, especially when a family is involved. When a family or individual is in need of emergency hospitalization and extensive medical care, it is more beneficial for the family or individual to put forth their own case and get what they need immediately rather than waiting for the class action to move forward.
If you believe that you have suffered from a complication after using an SGLT2 inhibitor, contact your physician for a medical workup and treatment plan. When it is determined that your complication may have been related to the use of the SGLT2 inhibitor, contact a lawyer for a consultation to see if you can make a case.